• Education
    • Higher Education
    • Scholarships & Grants
    • Online Learning
    • School Reforms
    • Research & Innovation
  • Lifestyle
    • Travel
    • Food & Drink
    • Fashion & Beauty
    • Home & Living
    • Relationships & Family
  • Technology & Startups
    • Software & Apps
    • Startup Success Stories
    • Startups & Innovations
    • Tech Regulations
    • Venture Capital
    • Artificial Intelligence
    • Cybersecurity
    • Emerging Technologies
    • Gadgets & Devices
    • Industry Analysis
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy
Today Headline
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
Today Headline
No Result
View All Result
Home Science & Environment Medical Research

How Navneet Kaur Is Championing Regulatory Excellence In The Pharmaceutical Industry

December 17, 2024
in Medical Research
Reading Time: 6 mins read
A A
0
Navneet Kaur
7
SHARES
15
VIEWS
Share on FacebookShare on Twitter


Navneet Kaur
Navneet Kaur
Supplied

Navneet Kaur, a seasoned Senior Manager in Regulatory Affairs, embarked on her journey driven by a deep passion for science and a commitment to improving patient health. Her academic foundation includes a Bachelor’s and Master’s in Chemistry (Honors) from Guru Nanak Dev University, an M.S. in Regulatory Affairs for Drugs, Biologics, and Medical Devices from Northeastern University, and over a decade of rigorous training in compliance and regulatory practices. She has built a career that seamlessly blends technical expertise with strategic decision-making. Kaur’s extensive experience spans multiple markets, including the United States, Europe, Canada, Australia, and Brazil, making her an asset in navigating the global regulatory environment.

“Every product represents hope for countless patients, and it’s my job to navigate the intricate regulatory pathways, specifically in chemistry manufacturing and controls to make that hope a reality,” Navneet shares.

Understanding the Risks

Spending the early years of her professional life in quality and compliance, Kaur gained a profound understanding of the high stakes involved when quality, safety, and efficacy do not meet the required standards. With an average of over 1,284 drugs recalled annually, the pharmaceutical industry demands vigilance. Quality control issues, ranging from incorrect labeling to contamination, can result in costly recalls, regulatory fines, and reputational damage.

Thankfully, there are many ways to prevent these setbacks, particularly through audits and regulatory inspections. A quality management system helps identify potential issues before they escalate, ensuring compliance with regulations and maintaining the safety and efficacy of pharmaceutical products. Regular audits also help catch discrepancies early, reducing the risk of significant financial and operational impacts​​.

The Power of Prevention

Preventing setbacks is paramount, and Kaur recognizes the importance of audits and regulatory inspections. A strong quality management system not only identifies potential issues early but also ensures compliance with regulations while maintaining the safety and efficacy of pharmaceutical products. Regular audits catch discrepancies, mitigating financial and operational risks. Kaur’s expertise in this area has been instrumental in safeguarding the integrity of numerous pharmaceutical products.

From Quality Control to Regulatory Mastery

Kaur started her professional journey at Ultra-Chiron Pharmaceuticals as a quality control analyst, where she developed her skills in product testing, on-the-floor quality assurance, drug product reviews, and compliance. At Parabolic Drugs Ltd., she played a pivotal role in establishing a stability testing laboratory for Active Pharmaceutical Ingredients (APIs), ensuring compliance with ICH guidelines. As a quality assurance officer at Ranbaxy Laboratories Ltd. (now Sun Pharmaceuticals Ltd.), Kaur managed deviations, conducted root cause analyses, implemented corrective and preventive actions (CAPAs), and collaborated with various departments to ensure adherence to regulatory standards.

Global Regulatory Prowess

Kaur’s move to the United States further solidified her regulatory expertise. At Sanofi Genzyme, she provided critical support for a remediation project, reviewing, assessing, and approving key documentation required to comply with FDA expectations. Hired as a Corrective and Preventive Actions (CAPA) expert, she addressed critical non-compliance issues for a pharmaceutical company in Cambridge, MA. She thoroughly assessed the vendor management system and prepared efficient processes to ensure the organization’s continued success. Her ability to review and approve crucial documentation—from Master Batch Records and deviations to analytical data and defining successful CAPAs—demonstrated her capacity to handle complex compliance issues effectively.

She began her journey in regulatory affairs as an Associate, progressing to Senior Regulatory Affairs Associate at Johnson Matthey Pharmaceutical Services (now Veranova). At the Devens site in Massachusetts, she was pivotal in managing regulatory activities, developing submission strategies for drug substances supporting Investigational New Drug (IND) applications, and Abbreviated New Drug Applications (ANDAs). Her expertise extended to authoring and reviewing Module 3 documentation for drug substances, Drug Master Files (DMFs), and Active Substance Master Files (ASMFs), preparing comprehensive risk assessments, and ensuring compliance with evolving regulatory requirements—managed amendments and life cycle for all the products.

Her proficiency in navigating the complex regulatory landscape ensured timely, high-quality submissions. Among her notable achievements, she successfully prepared and submitted drug substance dossiers for an oncology generic product to both the FDA and Brazil’s health authorities, leading to approvals in both markets and facilitating access to affordable oncology treatments. Additionally, she prepared and submitted a Drug Master File (DMF) dossier to Health Canada for a cardiovascular drug, which received approval and has since made a meaningful impact on patient care.

Kaur has obtained Certificates of Pharmaceutical Products (CPP) for various countries on behalf of a prominent pharmaceutical client. A CPP, issued by the regulatory authority in the exporting country, serves to confirm that a pharmaceutical product adheres to rigorous quality, safety, and efficacy standards. This document is essential for the legal importation and distribution of medications in foreign markets, ensuring compliance with international drug manufacturing and distribution regulations while facilitating the global flow of quality-assured pharmaceuticals.

Furthermore, Kaur has applied her extensive knowledge of the International Council for Harmonization (ICH) Q3D guidelines to conduct thorough risk assessments for multiple products. These assessments have critically evaluated the necessity for additional control strategies to ensure that elemental impurities (EIs) adhere to the Permitted Daily Exposure (PDE) limits, thereby reinforcing product safety and ensuring regulatory compliance.

Driving Excellence at Alkermes Inc.

In her current role at Alkermes Inc., Kaur continues to drive regulatory excellence. She collaborates with internal partners to develop regulatory Chemistry Manufacturing and Controls (CMC) strategies, preparing comprehensive clinical trial applications (CTAs), INDs and IMPDs (Investigational Medicinal Product Dossier). Her responsibilities extend to assessing, classifying, and performing regulatory impacts on the drug product changes. Her strategic mindset ensures that regulatory risks are identified early, safeguarding development projects. She is proficient in managing the CMC lifecycle.

The Future of Regulatory Affairs

As the pharmaceutical industry evolves, regulatory affairs professionals like Navneet Kaur are becoming increasingly vital. Her strategic approach, meticulous attention to detail, and ability to navigate complex regulations make her an invaluable asset. Kaur’s journey serves as an inspiration for aspiring regulatory professionals, highlighting the importance of strategic thinking, continuous learning, and a commitment to excellence.

In an industry where the stakes are high and the margin for error is slim, Kaur stands out as a leader who consistently delivers regulatory excellence. Her capacity to prevent setbacks, navigate global regulations, and foster a collaborative environment ensures that pharmaceutical products meet the highest standards of quality, safety, and efficacy. As the industry looks to the future, professionals like Kaur will continue to shape the regulatory landscape and safeguard patient health and well-being worldwide.



Navneet Kaur
Navneet Kaur
Supplied

Navneet Kaur, a seasoned Senior Manager in Regulatory Affairs, embarked on her journey driven by a deep passion for science and a commitment to improving patient health. Her academic foundation includes a Bachelor’s and Master’s in Chemistry (Honors) from Guru Nanak Dev University, an M.S. in Regulatory Affairs for Drugs, Biologics, and Medical Devices from Northeastern University, and over a decade of rigorous training in compliance and regulatory practices. She has built a career that seamlessly blends technical expertise with strategic decision-making. Kaur’s extensive experience spans multiple markets, including the United States, Europe, Canada, Australia, and Brazil, making her an asset in navigating the global regulatory environment.

“Every product represents hope for countless patients, and it’s my job to navigate the intricate regulatory pathways, specifically in chemistry manufacturing and controls to make that hope a reality,” Navneet shares.

Understanding the Risks

Spending the early years of her professional life in quality and compliance, Kaur gained a profound understanding of the high stakes involved when quality, safety, and efficacy do not meet the required standards. With an average of over 1,284 drugs recalled annually, the pharmaceutical industry demands vigilance. Quality control issues, ranging from incorrect labeling to contamination, can result in costly recalls, regulatory fines, and reputational damage.

Thankfully, there are many ways to prevent these setbacks, particularly through audits and regulatory inspections. A quality management system helps identify potential issues before they escalate, ensuring compliance with regulations and maintaining the safety and efficacy of pharmaceutical products. Regular audits also help catch discrepancies early, reducing the risk of significant financial and operational impacts​​.

The Power of Prevention

Preventing setbacks is paramount, and Kaur recognizes the importance of audits and regulatory inspections. A strong quality management system not only identifies potential issues early but also ensures compliance with regulations while maintaining the safety and efficacy of pharmaceutical products. Regular audits catch discrepancies, mitigating financial and operational risks. Kaur’s expertise in this area has been instrumental in safeguarding the integrity of numerous pharmaceutical products.

From Quality Control to Regulatory Mastery

Kaur started her professional journey at Ultra-Chiron Pharmaceuticals as a quality control analyst, where she developed her skills in product testing, on-the-floor quality assurance, drug product reviews, and compliance. At Parabolic Drugs Ltd., she played a pivotal role in establishing a stability testing laboratory for Active Pharmaceutical Ingredients (APIs), ensuring compliance with ICH guidelines. As a quality assurance officer at Ranbaxy Laboratories Ltd. (now Sun Pharmaceuticals Ltd.), Kaur managed deviations, conducted root cause analyses, implemented corrective and preventive actions (CAPAs), and collaborated with various departments to ensure adherence to regulatory standards.

Global Regulatory Prowess

Kaur’s move to the United States further solidified her regulatory expertise. At Sanofi Genzyme, she provided critical support for a remediation project, reviewing, assessing, and approving key documentation required to comply with FDA expectations. Hired as a Corrective and Preventive Actions (CAPA) expert, she addressed critical non-compliance issues for a pharmaceutical company in Cambridge, MA. She thoroughly assessed the vendor management system and prepared efficient processes to ensure the organization’s continued success. Her ability to review and approve crucial documentation—from Master Batch Records and deviations to analytical data and defining successful CAPAs—demonstrated her capacity to handle complex compliance issues effectively.

She began her journey in regulatory affairs as an Associate, progressing to Senior Regulatory Affairs Associate at Johnson Matthey Pharmaceutical Services (now Veranova). At the Devens site in Massachusetts, she was pivotal in managing regulatory activities, developing submission strategies for drug substances supporting Investigational New Drug (IND) applications, and Abbreviated New Drug Applications (ANDAs). Her expertise extended to authoring and reviewing Module 3 documentation for drug substances, Drug Master Files (DMFs), and Active Substance Master Files (ASMFs), preparing comprehensive risk assessments, and ensuring compliance with evolving regulatory requirements—managed amendments and life cycle for all the products.

Her proficiency in navigating the complex regulatory landscape ensured timely, high-quality submissions. Among her notable achievements, she successfully prepared and submitted drug substance dossiers for an oncology generic product to both the FDA and Brazil’s health authorities, leading to approvals in both markets and facilitating access to affordable oncology treatments. Additionally, she prepared and submitted a Drug Master File (DMF) dossier to Health Canada for a cardiovascular drug, which received approval and has since made a meaningful impact on patient care.

Kaur has obtained Certificates of Pharmaceutical Products (CPP) for various countries on behalf of a prominent pharmaceutical client. A CPP, issued by the regulatory authority in the exporting country, serves to confirm that a pharmaceutical product adheres to rigorous quality, safety, and efficacy standards. This document is essential for the legal importation and distribution of medications in foreign markets, ensuring compliance with international drug manufacturing and distribution regulations while facilitating the global flow of quality-assured pharmaceuticals.

Furthermore, Kaur has applied her extensive knowledge of the International Council for Harmonization (ICH) Q3D guidelines to conduct thorough risk assessments for multiple products. These assessments have critically evaluated the necessity for additional control strategies to ensure that elemental impurities (EIs) adhere to the Permitted Daily Exposure (PDE) limits, thereby reinforcing product safety and ensuring regulatory compliance.

Driving Excellence at Alkermes Inc.

In her current role at Alkermes Inc., Kaur continues to drive regulatory excellence. She collaborates with internal partners to develop regulatory Chemistry Manufacturing and Controls (CMC) strategies, preparing comprehensive clinical trial applications (CTAs), INDs and IMPDs (Investigational Medicinal Product Dossier). Her responsibilities extend to assessing, classifying, and performing regulatory impacts on the drug product changes. Her strategic mindset ensures that regulatory risks are identified early, safeguarding development projects. She is proficient in managing the CMC lifecycle.

The Future of Regulatory Affairs

As the pharmaceutical industry evolves, regulatory affairs professionals like Navneet Kaur are becoming increasingly vital. Her strategic approach, meticulous attention to detail, and ability to navigate complex regulations make her an invaluable asset. Kaur’s journey serves as an inspiration for aspiring regulatory professionals, highlighting the importance of strategic thinking, continuous learning, and a commitment to excellence.

In an industry where the stakes are high and the margin for error is slim, Kaur stands out as a leader who consistently delivers regulatory excellence. Her capacity to prevent setbacks, navigate global regulations, and foster a collaborative environment ensures that pharmaceutical products meet the highest standards of quality, safety, and efficacy. As the industry looks to the future, professionals like Kaur will continue to shape the regulatory landscape and safeguard patient health and well-being worldwide.


Tags: Navneet KaurPharmaceutical Industryregulatory excellence
Previous Post

Outgoing Washington governor suggests ‘wealth tax’ to avoid cuts to education and police

Next Post

You ain’t seen nothing yet! ‘The Outer Worlds 2’ gets wild new trailer at The Game Awards

Related Posts

Tribes Question Kennedy’s Promise To Protect Them From Health Cuts

June 6, 2025
9
Novel food-oriented large language model tackling data challenges to advance nutritional applications

Food-oriented LLM tackles data challenges to advance nutritional applications

June 6, 2025
6
Next Post
The Outer Worlds 2: First Gameplay Trailer - YouTube

You ain’t seen nothing yet! 'The Outer Worlds 2' gets wild new trailer at The Game Awards

  • Trending
  • Comments
  • Latest
Family calls for change after B.C. nurse dies by suicide after attacks on the job

Family calls for change after B.C. nurse dies by suicide after attacks on the job

April 2, 2025
Pioneering 3D printing project shares successes

Product reduces TPH levels to non-hazardous status

November 27, 2024

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

December 31, 2024

Police ID man who died after Corso Italia fight

December 23, 2024
Harris tells supporters 'never give up' and urges peaceful transfer of power

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

0
Des Moines Man Accused Of Shooting Ex-Girlfriend's Mother

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

0

Trump ‘looks forward’ to White House meeting with Biden

0
Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

0
SNP to "learn lessons" as Labour wins crucial by-election

SNP to “learn lessons” as Labour wins crucial by-election

June 6, 2025
LPA, habagat will continue to bring rains across PH

LPA, habagat will continue to bring rains across PH

June 6, 2025
US Supreme Court grants DOGE access to sensitive Social Security data

US Supreme Court grants DOGE access to sensitive Social Security data

June 6, 2025
Kilmar Abrego Garcia being returned to U.S. to face charges of transporting illegal immigrants

Kilmar Abrego Garcia being returned to U.S. to face charges of transporting illegal immigrants

June 6, 2025

Recent News

SNP to "learn lessons" as Labour wins crucial by-election

SNP to “learn lessons” as Labour wins crucial by-election

June 6, 2025
0
LPA, habagat will continue to bring rains across PH

LPA, habagat will continue to bring rains across PH

June 6, 2025
2
US Supreme Court grants DOGE access to sensitive Social Security data

US Supreme Court grants DOGE access to sensitive Social Security data

June 6, 2025
5
Kilmar Abrego Garcia being returned to U.S. to face charges of transporting illegal immigrants

Kilmar Abrego Garcia being returned to U.S. to face charges of transporting illegal immigrants

June 6, 2025
4

TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.

Follow Us

Browse by Category

  • Africa
  • Asia
  • Basketball
  • Business & Finance
  • Climate Change
  • Crime & Justice
  • Cybersecurity
  • Economic Policies
  • Elections
  • Entertainment
  • Entrepreneurship
  • Environmental Policies
  • Europe
  • Football
  • Gadgets & Devices
  • Health
  • Medical Research
  • Mental Health
  • Middle East
  • Motorsport
  • Olympics
  • Politics
  • Public Health
  • Relationships & Family
  • Science & Environment
  • Software & Apps
  • Space Exploration
  • Sports
  • Stock Market
  • Technology & Startups
  • Tennis
  • Travel
  • Uncategorized
  • Us & Canada
  • Wildlife & Conservation
  • World News

Recent News

SNP to "learn lessons" as Labour wins crucial by-election

SNP to “learn lessons” as Labour wins crucial by-election

June 6, 2025
LPA, habagat will continue to bring rains across PH

LPA, habagat will continue to bring rains across PH

June 6, 2025
  • Education
  • Lifestyle
  • Technology & Startups
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy

© 2024 Todayheadline.co

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business & Finance
  • Corporate News
  • Economic Policies
  • Entrepreneurship
  • Market Trends
  • Crime & Justice
  • Court Cases
  • Criminal Investigations
  • Cybercrime
  • Legal Reforms
  • Policing
  • Education
  • Higher Education
  • Online Learning
  • Entertainment
  • Awards & Festivals
  • Celebrity News
  • Movies
  • Music
  • Health
  • Fitness & Nutrition
  • Medical Breakthroughs
  • Mental Health
  • Pandemic Updates
  • Lifestyle
  • Fashion & Beauty
  • Food & Drink
  • Home & Living
  • Politics
  • Elections
  • Government Policies
  • International Relations
  • Legislative News
  • Political Parties
  • Africa
  • Asia
  • Europe
  • Middle East
  • Artificial Intelligence
  • Cybersecurity
  • Emerging Technologies
  • Gadgets & Devices
  • Industry Analysis
  • Basketball
  • Football
  • Motorsport
  • Olympics
  • Climate Change
  • Environmental Policies
  • Medical Research
  • Science & Environment
  • Space Exploration
  • Wildlife & Conservation
  • Sports
  • Tennis
  • Technology & Startups
  • Software & Apps
  • Startup Success Stories
  • Startups & Innovations
  • Tech Regulations
  • Venture Capital
  • Uncategorized
  • World News
  • Us & Canada
  • Public Health
  • Relationships & Family
  • Travel
  • Research & Innovation
  • Scholarships & Grants
  • School Reforms
  • Stock Market
  • TV & Streaming
  • Advertise with Us
  • Privacy & Policy
  • About us
  • Contact

© 2024 Todayheadline.co